Skip to main content
Log in

Experimental metastasis is suppressed in MMP-9-deficient mice

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Matrix metalloproteinases (MMPs) are thought to play a key role in tumor invasion and metastasis. The role of MMP-9 (gelatinase B) in tumor metastasis was examined in MMP-9-deficient mice produced by gene targeting using embryonic stem cells. MMP-9-deficient mice develop normally and are fertile. In these mice, the number of metastatic colonies of B16-BL6 melanoma cells or Lewis lung carcinoma cells that were implanted intravenously fell by 45% for B16-BL6 melanoma and 59% for Lewis lung carcinoma (p=0.03 and p=0.0043, respectively). Gelatin zymography showed that both tumor cell lines did not secrete MMP-9 by themselves but the host cells surrounding the tumor cells secrete MMP-9 in vivo. These results indicated that host-derived MMP-9 plays an important role in the process of tumor metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145–2154.

    Google Scholar 

  2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121–125.

    Google Scholar 

  3. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA. The activation of human type IV collagenase proenzyme. Biol Chem. 1989; 264: 1353–1356.

    Google Scholar 

  4. Docherty AJP, Lyons A, Smith BJ, et al. Sequence of human tissue inhibitor f metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 66–69.

    Google Scholar 

  5. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of etalloproteinase (TIMP-2). J Biol Chem 1989 264: 17374–17378.

    Google Scholar 

  6. Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates ith enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67–68.

    Google Scholar 

  7. Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion & Metastasis 1995; 14: 246–258.

    Google Scholar 

  8. Stetler-Stevenson WG. Progelatinase A activation during tumor cell nvasion. Invasion & Metastasis 1995; 14: 259–268.

    Google Scholar 

  9. Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA. Matrix etalloproteinases-2 and-9 are expressed in human neuroblastoma: ontribution of stromal cells to their production and correlation with metastasis. Cancer Res 1988; 58: 2209–2216.

    Google Scholar 

  10. Nielsen BS, Timshel S, Kjeldsen L et al. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 1996; 65: 57–62.

    Google Scholar 

  11. Segain JP, Harb J, Grégoire M, Meflah K, Menanteau J. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res 1996; 56: 5506–5512.

    Google Scholar 

  12. Himelstein BP, Canete-Soler R, Bernhard EJ, Muschel RJ. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 1994; 107: 477–486.

    Google Scholar 

  13. Itoh T, Ikeda T, Gomi H et al. Unaltered secretion of β-amyloid precursor protein in gelatinase A (Matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997; 272: 22389–22392.

    Google Scholar 

  14. Itoh T, Tanioka M, Yoshida H et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048–1051.

    Google Scholar 

  15. Yagi T, Ikawa Y, Yoshida K, et al. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin Afragment gene in negative selection. Proc Natl Acad Sci USA 1990; 87: 9918–9922.

    Google Scholar 

  16. Gomi H, Yokoyama T, Fujimoto K et al. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995; 14: 29–41.

    Google Scholar 

  17. Hart IR. The selection and characterization of an invasive variant of the B16 melanoma. Am J Path 1979; 97: 587–600.

    Google Scholar 

  18. Uehira M, Matsuda H, Nakamura A, Nishimoto H. Immunologic abnormalities exhibited in IL-7 transgenic mice with dermatitis. J Invest Dermatol 1998; 110: 740–745.

    Google Scholar 

  19. Raz A, McLellan WL, Hart IR et al. Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res 1980; 40: 1645–1651.

    Google Scholar 

  20. Vu TH, Shipley JM, Bergers G et al. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411–422.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itoh, T., Tanioka, M., Matsuda, H. et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17, 177–181 (1999). https://doi.org/10.1023/A:1006603723759

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006603723759

Navigation